ArticleRegenerative therapy2026
FOXO1-mediated cell cycle arrest enhances osteogenic differentiation of spheroid-cultured human periodontal ligament-derived multipotent mesenchymal stromal cells.
Article in Regenerative therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Periodontitis is a chronic inflammatory disease characterized by progressive alveolar bone loss. Although spheroid culture enhances the osteogenic and regenerative potential of human periodontal ligament-derived multipotent mesenchymal stromal cells (hPDLMSCs), the underlying molecular mechanisms remain unclear. This study aimed to investigate the transcriptional features of spheroid-cultured hPDLMSCs, with a particular focus on cell cycle regulation and Forkhead Box O (FOXO) transcription factors. Methods: Monolayer- and spheroid-cultured hPDLMSCs were subjected to transcriptome analysis using RNA sequencing. Differentially expressed genes and enriched signaling pathways were identified, followed by validation through qRT-PCR and Western blotting. Flow cytometric analysis was then performed to compare cell cycle characteristics between monolayer- and spheroid-cultured hPDLMSCs. The functional roles of FOXO1 and FOXO4 were examined using siRNA-mediated knockdown combined with cell cycle and osteogenic differentiation analyses. Results: Transcriptome analysis revealed significant alterations in cell cycle-related genes and FOXO signaling in spheroid-cultured hPDLMSCs, including downregulation of cyclin family genes associated with cell cycle progression. Spheroid culture induced cell cycle arrest, characterized by an increased G0/G1 phase population and elevated expression of FOXO1, FOXO4, and cyclin-dependent kinase inhibitors (CDKN1A, CDKN1B, and CDKN1C). FOXO1 knockdown promoted cell cycle progression and markedly reduced stemness and osteogenic marker expression as well as alkaline phosphatase activity. Similarly, FOXO4 knockdown decreased stemness-related gene expression but had a limited effect on osteogenic differentiation. Conclusions: FOXO1-mediated cell cycle regulation supports the maintenance of stemness and osteogenic potential in spheroid-cultured hPDLMSCs, suggesting that FOXO1 may serve as a promising target for periodontal tissue regeneration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.